User: I want to know more about the compound with SMILES C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O.
Assistant: That sounds interesting, how can I help?
User: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Assistant: Phase 3 Clinical Trials
User: I want to know more about the {#molecule|chemical|compound!} with {SMILES__description} {SMILES#}.
Assistant: {#Sure, what is your question?|How can I help?|That sounds interesting, how can I help?|Interesting, how can I help?!}
User: {quest#}
Assistant: {#The answer is |!}{answ#}
C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O
C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonicacid
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.